FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3181683941> ?p ?o ?g. }

• W3181683941 endingPage "109572" @default.
• W3181683941 startingPage "109572" @default.
• W3181683941 abstract "Oxidized low-density lipoprotein (ox-LDL) not only causes hyperlipidemia and contributes to atherosclerosis but also induces the endothelial dysfunction that leads to cardiovascular diseases. The nuclear factor-kappa B (NF-κB) pathway plays a key role in many chronic disorders and is a transcriptional factor in various inflammatory responses. The present study aimed to investigate the synergistic effects of pelargonic acid vanillylamide (PAVA) and rosuvastatin (RSV) on ox-LDL-induced inflammatory responses in human vascular endothelial cells (HUV-EC-C). HUV-EC-C were pretreated with PAVA or RSV and their combination for 2 h followed by ox-LDL for 24 h. The MTT assay was used to measure mitochondrial function. The DCFH-DA assay was used to evaluate oxidative phosphorylation, and western blotting was used to measured NF-κB/NLRP3 and related signaling pathways in HUV-EC-C. Ox-LDL induced lectin-type oxidized LDL receptor 1 (LOX-1) expression, NADPH oxidase 4 activation, and the overexpression of reactive oxygen species, which were inhibited by pretreatment with the combination of PAVA and RSV. Moreover, PAVA and RSV inhibited ox-LDL-induced NF-κBp65 activation. Ox-LDL induced NF-κB/NLRP3 pathway activation by inducing C-reactive protein expression, NLRP3 activation, caspase-1 activation, and IL-1β secretion, which were inhibited by pretreatment with the combination of PAVA and RSV. The combination of PAVA and RSV reduced ox-LDL-induced recruitment of monocytes to the site of inflammation, inhibited activation of the NLRP3 inflammasome, and ameliorated the impairment of cell-cell junctions through the NF-κB pathway. Our results suggest that the synergistic effects of PAVA and RSV provide a novel mechanism for the treatment of cardiovascular diseases." @default.
• W3181683941 created "2021-07-19" @default.
• W3181683941 creator A5014356405 @default.
• W3181683941 creator A5026011880 @default.
• W3181683941 creator A5030020974 @default.
• W3181683941 creator A5033462993 @default.
• W3181683941 creator A5035355701 @default.
• W3181683941 creator A5064012487 @default.
• W3181683941 date "2021-08-01" @default.
• W3181683941 modified "2023-10-16" @default.
• W3181683941 title "Pelargonic acid vanillylamide and rosuvastatin protect against oxidized low-density lipoprotein-induced endothelial dysfunction by inhibiting the NF-κB/NLRP3 pathway and improving cell-cell junctions" @default.
• W3181683941 cites W1589192932 @default.
• W3181683941 cites W1711797882 @default.
• W3181683941 cites W1757834753 @default.
• W3181683941 cites W1967996568 @default.
• W3181683941 cites W1989509611 @default.
• W3181683941 cites W1991416826 @default.
• W3181683941 cites W1993429855 @default.
• W3181683941 cites W1997557110 @default.
• W3181683941 cites W2038861298 @default.
• W3181683941 cites W2050752415 @default.
• W3181683941 cites W2077549620 @default.
• W3181683941 cites W2096626379 @default.
• W3181683941 cites W2103379516 @default.
• W3181683941 cites W2106064607 @default.
• W3181683941 cites W2111419779 @default.
• W3181683941 cites W2121485938 @default.
• W3181683941 cites W2127369603 @default.
• W3181683941 cites W2140998385 @default.
• W3181683941 cites W2171056569 @default.
• W3181683941 cites W2275879522 @default.
• W3181683941 cites W2317629072 @default.
• W3181683941 cites W2325332831 @default.
• W3181683941 cites W2347123634 @default.
• W3181683941 cites W2475158607 @default.
• W3181683941 cites W2524054199 @default.
• W3181683941 cites W2527829175 @default.
• W3181683941 cites W2535421876 @default.
• W3181683941 cites W2594448523 @default.
• W3181683941 cites W2619173475 @default.
• W3181683941 cites W2620254432 @default.
• W3181683941 cites W2623250711 @default.
• W3181683941 cites W2763335706 @default.
• W3181683941 cites W2767765728 @default.
• W3181683941 cites W2770016955 @default.
• W3181683941 cites W2818594419 @default.
• W3181683941 cites W2889555654 @default.
• W3181683941 cites W2900445599 @default.
• W3181683941 cites W2901171191 @default.
• W3181683941 cites W2903758787 @default.
• W3181683941 cites W2907119987 @default.
• W3181683941 cites W2947268334 @default.
• W3181683941 cites W3000070916 @default.
• W3181683941 doi "https://doi.org/10.1016/j.cbi.2021.109572" @default.
• W3181683941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34217687" @default.
• W3181683941 hasPublicationYear "2021" @default.
• W3181683941 type Work @default.
• W3181683941 sameAs 3181683941 @default.
• W3181683941 citedByCount "7" @default.
• W3181683941 countsByYear W31816839412022 @default.
• W3181683941 countsByYear W31816839412023 @default.
• W3181683941 crossrefType "journal-article" @default.
• W3181683941 hasAuthorship W3181683941A5014356405 @default.
• W3181683941 hasAuthorship W3181683941A5026011880 @default.
• W3181683941 hasAuthorship W3181683941A5030020974 @default.
• W3181683941 hasAuthorship W3181683941A5033462993 @default.
• W3181683941 hasAuthorship W3181683941A5035355701 @default.
• W3181683941 hasAuthorship W3181683941A5064012487 @default.
• W3181683941 hasConcept C100175707 @default.
• W3181683941 hasConcept C153911025 @default.
• W3181683941 hasConcept C185592680 @default.
• W3181683941 hasConcept C2777730290 @default.
• W3181683941 hasConcept C2779719074 @default.
• W3181683941 hasConcept C2780499067 @default.
• W3181683941 hasConcept C48349386 @default.
• W3181683941 hasConcept C55493867 @default.
• W3181683941 hasConcept C62478195 @default.
• W3181683941 hasConcept C71924100 @default.
• W3181683941 hasConcept C86803240 @default.
• W3181683941 hasConcept C98274493 @default.
• W3181683941 hasConceptScore W3181683941C100175707 @default.
• W3181683941 hasConceptScore W3181683941C153911025 @default.
• W3181683941 hasConceptScore W3181683941C185592680 @default.
• W3181683941 hasConceptScore W3181683941C2777730290 @default.
• W3181683941 hasConceptScore W3181683941C2779719074 @default.
• W3181683941 hasConceptScore W3181683941C2780499067 @default.
• W3181683941 hasConceptScore W3181683941C48349386 @default.
• W3181683941 hasConceptScore W3181683941C55493867 @default.
• W3181683941 hasConceptScore W3181683941C62478195 @default.
• W3181683941 hasConceptScore W3181683941C71924100 @default.
• W3181683941 hasConceptScore W3181683941C86803240 @default.
• W3181683941 hasConceptScore W3181683941C98274493 @default.
• W3181683941 hasLocation W31816839411 @default.
• W3181683941 hasOpenAccess W3181683941 @default.
• W3181683941 hasPrimaryLocation W31816839411 @default.
• W3181683941 hasRelatedWork W2035153027 @default.
• W3181683941 hasRelatedWork W2066371867 @default.
• W3181683941 hasRelatedWork W2086667809 @default.

• next